Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Ford Investor Services, Inc.
Provider : Wright Reports
Provider : Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cellular Biomedicine Group announces discontinuation of consulting business segment

Monday, 30 Jun 2014 09:05am EDT 

Cellular Biomedicine Group Inc:Announces the discontinuation of the company's consulting business segment.Consulting business is expected to be classified as discontinued operations, effective July 1.Expects to record a one-time pre-tax cash charge of about $840,000 in the second quarter 2014 resulting from severance to be paid to employees affiliated with the consulting business. 

Company Quote

0.71 +3.11%
28 Aug 2015